CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


07-June-2016
Introducing the latest stable-labeled therapeutic drug monitoring (TDM) standard from Cerilliant, Busulfan-D8.

Busulfan-D8, 100 ug/mL, 1mL B-068
100 ug/mL in Methanol

Used in the treatment of cancer, busulfan is an alkylating antineoplastic drug monitored by clinical labs to ensure patients remain within the drug’s therapeutic range. Adverse reactions to busulfan include vomiting, anorexia, anemia, infertility and bone marrow suppression. This stable-labeled internal standard is suitable for quantification of busulfan levels by GC/MS or LC-MS/MS for applications such as therapeutic drug monitoring or clinical and diagnostic testing.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn